Rolf Anders Syvertsen
Overview
Explore the profile of Rolf Anders Syvertsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cyll K, Haug E, Pradhan M, Vlatkovic L, Carlsen B, Loffeler S, et al.
Br J Cancer
. 2024 Jul;
131(5):895-904.
PMID: 38961192
Background: Current risk stratification tools for prostate cancer patients under active surveillance (AS) may inadequately identify those needing treatment. We investigated DNA ploidy and PTEN as potential biomarkers to predict...
2.
Nielsen B, Kleppe A, Hveem T, Pradhan M, Syvertsen R, Nesheim J, et al.
J Natl Cancer Inst
. 2018 Apr;
110(12):1400-1408.
PMID: 29684152
Background: Nuclear texture analysis measuring differences in chromatin structure has provided prognostic biomarkers in several cancers. There is a need for improved cell-by-cell chromatin analysis to detect nuclei with highly...
3.
Hveem T, Njolstad T, Nielsen B, Syvertsen R, Nesheim J, Kjaereng M, et al.
Cancer Epidemiol Biomarkers Prev
. 2016 Sep;
26(1):61-67.
PMID: 27587790
Background: Most endometrial carcinoma patients are diagnosed at an early stage with a good prognosis. However, a relatively low fraction with lethal disease constitutes a substantial number of patients due...
4.
Hveem T, Kleppe A, Vlatkovic L, Ersvaer E, Waehre H, Nielsen B, et al.
Br J Cancer
. 2016 Apr;
114(11):1243-50.
PMID: 27124335
Background: Pathological evaluations give the best prognostic markers for prostate cancer patients after radical prostatectomy, but the observer variance is substantial. These risk assessments should be supported and supplemented by...